Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $0.

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.